“A means of quantifying the risk of SARS-CoV-2 airborne transmission in a standardized manner (using a standardized model) in residential, public and health care settings is essential to inform non-pharmaceutical risk reduction measures, such as increasing ventilation, air cleaning and disinfection, source control interventions, and controlling the occupancy, as well as to communicate the risk and enable informed decisions by the occupants.”
WHO : Indoor airborne risk assessment in the context of SARS-CoV-2
Previous
Previous
Lancet Preprint : Admission Screening Testing of Patients & Staff N95 Masks are Cost-Effective in Reducing COVID-19 Hospital Acquired Infections
Next
Next
